Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2.

Dietrich CG, Geier A, Salein N, Lammert F, Roeb E, Oude Elferink RP, Matern S, Gartung C.

Gastroenterology. 2004 Apr;126(4):1044-53.

PMID:
15057744
2.

Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis.

Denson LA, Bohan A, Held MA, Boyer JL.

Gastroenterology. 2002 Aug;123(2):599-607.

PMID:
12145812
4.

Bcrp1;Mdr1a/b;Mrp2 combination knockout mice: altered disposition of the dietary carcinogen PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) and its genotoxic metabolites.

Vlaming ML, Teunissen SF, van de Steeg E, van Esch A, Wagenaar E, Brunsveld L, de Greef TF, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.

Mol Pharmacol. 2014 Mar;85(3):520-30. doi: 10.1124/mol.113.088823. Epub 2013 Dec 13.

5.

Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.

Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, Takeuchi K, Iwasa M, Kaito M, Adachi Y.

Am J Physiol Gastrointest Liver Physiol. 2002 Apr;282(4):G656-62.

6.

Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis.

Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, Gartung C.

Hepatology. 2003 Aug;38(2):345-54.

PMID:
12883478
7.
8.

Role of breast cancer resistance protein in the adaptive response to cholestasis.

Mennone A, Soroka CJ, Harry KM, Boyer JL.

Drug Metab Dispos. 2010 Oct;38(10):1673-8. doi: 10.1124/dmd.110.034512. Epub 2010 Jul 2.

9.

Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen.

Dietrich CG, Geier A, Wasmuth HE, Matern S, Gartung C, de Waart DR, Elferink RP.

Gut. 2004 Dec;53(12):1850-5.

10.

The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.

Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, Suchy FJ, Keppler D, Boyer JL.

Gastroenterology. 1997 Jul;113(1):255-64.

PMID:
9207286
11.

Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.

Kalgutkar AS, Feng B, Nguyen HT, Frederick KS, Campbell SD, Hatch HL, Bi YA, Kazolias DC, Davidson RE, Mireles RJ, Duignan DB, Choo EF, Zhao SX.

Drug Metab Dispos. 2007 Nov;35(11):2111-8. Epub 2007 Aug 8.

12.

Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis.

Mühlfeld A, Kubitz R, Dransfeld O, Häussinger D, Wettstein M.

Arch Biochem Biophys. 2003 May 1;413(1):32-40.

PMID:
12706339
13.

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

Zollner G, Fickert P, Zenz R, Fuchsbichler A, Stumptner C, Kenner L, Ferenci P, Stauber RE, Krejs GJ, Denk H, Zatloukal K, Trauner M.

Hepatology. 2001 Mar;33(3):633-46.

PMID:
11230744
14.
15.

Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.

Chisaki I, Kobayashi M, Itagaki S, Hirano T, Iseki K.

Biochim Biophys Acta. 2009 Nov;1788(11):2396-403. doi: 10.1016/j.bbamem.2009.08.014. Epub 2009 Sep 1.

16.

Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis.

Zimmermann C, Hruz P, Gutmann H, Terracciano L, Beuers U, Lehmann F, Beglinger C, Drewe J.

Digestion. 2006;74(2):101-8. Epub 2006 Dec 7.

PMID:
17159348
17.

Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver.

Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, van Bokhoven I, van Marle J, Bolder U, Tytgat GN, Oude Elferink RP.

Hepatology. 2000 Mar;31(3):684-93.

PMID:
10706559
18.

Caffeic acid inhibits the uptake of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by inducing the efflux transporters expression in Caco-2 cells.

Hong YJ, Yang SY, Nam MH, Koo YC, Lee KW.

Biol Pharm Bull. 2015;38(2):201-7. doi: 10.1248/bpb.b14-00495. Epub 2014 Nov 15.

19.

Regulation of expression and activity of rat intestinal multidrug resistance-associated protein 2 by cholestatic estrogens.

Arias A, Villanueva SS, Ruiz ML, Luquita MG, Veggi LM, Pellegrino JM, Vore M, Catania VA, Mottino AD.

Drug Metab Dispos. 2009 Jun;37(6):1277-85. doi: 10.1124/dmd.108.025643. Epub 2009 Mar 19.

20.

Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.

Muchova L, Vanova K, Suk J, Micuda S, Dolezelova E, Fuksa L, Cerny D, Farghali H, Zelenkova M, Lenicek M, Wong RJ, Vreman HJ, Vitek L.

J Cell Mol Med. 2015 May;19(5):924-33. doi: 10.1111/jcmm.12401. Epub 2015 Feb 16.

Supplemental Content

Support Center